Our Resources | Association for Accessible Medicines

In the News - View AAM CEO Dan Leonard's blog on the essential role generic drugs play during COVID-19

Doctors and technology

Feb 5, 2021 | Erica Klinger

Cancer Costs and Options for Care in the United States

Dan Leonard, AAM President and CEO=

Feb 4, 2021 | Dan Leonard

While We Await the Vaccine, We Can Trust in Generic Drugs

My Prescription for Savings. It’s time for Congress to take meaningful action to lower prescription drug costs with the Prescription for Savings. Patients win when market-based competition from FDA-approved generics and biosimilars deliver savings at the pharmacy counter.

Jan 29, 2021 | Kristin Murphy

AAM’s Recommendations to #SecureOurMeds

USA flag with generic medicines

Jan 21, 2021 | Rachel Schwartz

AAM Statement on Biden’s Executive Orders to Strengthen America’s COVID Response

Friendly pharmacist hands a paper bag to young female customer at the checkout counter

Jan 15, 2021 | Rachel Schwartz

AAM and Biosimilars Council Statement on CMS Decision to Update Part D Program

Jan 6, 2021 | Dan Leonard

2021 Generics and Biosimilars Outlook

Jean Hoffman

Jan 4, 2021 | Bob Billings

Thank you, Jean Hoffman

Video

Dec 17, 2020 | Erica Klinger

Helen's Story — She Knows She Can Rely on Biosimilars

Helen, 41, from Florida, knows she can rely on biosimilars for her non-Hodgkin lymphoma

Dec 17, 2020 | Erica Klinger

Helen Knows She Can Rely on Biosimilars

GRx+Biosims 2020 Recap

Dec 17, 2020 | Erica Klinger

GRx+Biosims Recap: A Virtual Success

Oppose the Blocking Act #Preserve180

Dec 14, 2020 | Dan Leonard

Congress Should Preserve—Not Limit—Patient Access to New Generics

Katherine Tai

Dec 10, 2020 | Rachel Schwartz

AAM Statement on President-elect Biden Naming Katherine Tai as U.S. Trade Representative